Insights

More Articles Back to Article

Regulatory Agilities During the COVID-19 Pandemic Observations from a Multinational Pharmaceutical Company

The following practical actions were deployed by regulatory authorities and collectively experienced by industry to ensure the continued smooth functioning of regulatory systems during the pandemic. We propose that there is an imperative to continue to build on many of these actions to accelerate regulatory strengthening even further in international markets and to make some of these practices permanent.